Current, Emerging, and Anticipated Therapies for Sickle Cell Disease

Affiliations

¹ Division of Nephrology and Hypertension. Electronic address: nath.karl@mayo.edu.
² Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN.

Editorial

Karl A Nath et al. Mayo Clin Proc. 2018 Dec.

. 2018 Dec;93(12):1703-1706.

doi: 10.1016/j.mayocp.2018.10.010.

¹ Division of Nephrology and Hypertension. Electronic address: nath.karl@mayo.edu.
² Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN.

No abstract available

Comment on

Advances in the Treatment of Sickle Cell Disease.
Kapoor S, Little JA, Pecker LH. Kapoor S, et al. Mayo Clin Proc. 2018 Dec;93(12):1810-1824. doi: 10.1016/j.mayocp.2018.08.001. Epub 2018 Nov 7. Mayo Clin Proc. 2018. PMID: 30414734 Review.